GenBody - COVID-19 Antigen Rapid Test Kit

An immunochromatographic rapid diagnostic test (RDT) intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 in direct nasopharyngeal (NP) or anteriornasal (AN) swab specimens. Authorized for use under an Emergency Use Authorization (EUA) and for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

Most popular related searches

Kit Includes:

25 single use test devices, individually foil-pouched
2 bottles of extraction solution
25 single use extraction tubes
25 single use dropper tips
25 sterilized anterior nasal collection swabs
1 External positive control

Features and Benefits:

Rapid results:
Visual read-out in 15-20 minutes
Sensitivity:
Identifies acute infection with a 92.3% sensitivity and 99% specificity
Storage:
Between 2°C to 30°C